147 related articles for article (PubMed ID: 24452808)
1. Encapsulation of poorly soluble drugs in polymer-drug conjugates: effect of dual-drug nanoformulations on cancer therapy.
Senanayake TH; Lu Y; Bohling A; Raja S; Band H; Vinogradov SV
Pharm Res; 2014 Jun; 31(6):1605-15. PubMed ID: 24452808
[TBL] [Abstract][Full Text] [Related]
2. Application of activated nucleoside analogs for the treatment of drug-resistant tumors by oral delivery of nanogel-drug conjugates.
Senanayake TH; Warren G; Wei X; Vinogradov SV
J Control Release; 2013 Apr; 167(2):200-9. PubMed ID: 23385032
[TBL] [Abstract][Full Text] [Related]
3. Novel anticancer polymeric conjugates of activated nucleoside analogues.
Senanayake TH; Warren G; Vinogradov SV
Bioconjug Chem; 2011 Oct; 22(10):1983-93. PubMed ID: 21863885
[TBL] [Abstract][Full Text] [Related]
4. A green approach to dual-drug nanoformulations with targeting and synergistic effects for cancer therapy.
Wu S; Yang X; Lu Y; Fan Z; Li Y; Jiang Y; Hou Z
Drug Deliv; 2017 Nov; 24(1):51-60. PubMed ID: 28155539
[TBL] [Abstract][Full Text] [Related]
5. Polypeptide-based nanogels co-encapsulating a synergistic combination of doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer models.
Desale SS; Raja SM; Kim JO; Mohapatra B; Soni KS; Luan H; Williams SH; Bielecki TA; Feng D; Storck M; Band V; Cohen SM; Band H; Bronich TK
J Control Release; 2015 Jun; 208():59-66. PubMed ID: 25660204
[TBL] [Abstract][Full Text] [Related]
6. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
7. RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy.
Wang G; Wang Z; Li C; Duan G; Wang K; Li Q; Tao T
Biomed Pharmacother; 2018 Oct; 106():275-284. PubMed ID: 29966971
[TBL] [Abstract][Full Text] [Related]
8. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.
Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ
J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307
[TBL] [Abstract][Full Text] [Related]
9. Internal cross-linked polymeric nanoparticles with dual sensitivity for combination therapy of muscle-invasive bladder cancer.
Zhu G; Wang K; Qin H; Zhao X; Chen W; Xu L; Cao W; Guo H
J Nanobiotechnology; 2020 Sep; 18(1):124. PubMed ID: 32887622
[TBL] [Abstract][Full Text] [Related]
10. Anticancer polymeric nanomedicine bearing synergistic drug combination is superior to a mixture of individually-conjugated drugs.
Markovsky E; Baabur-Cohen H; Satchi-Fainaro R
J Control Release; 2014 Aug; 187():145-57. PubMed ID: 24862318
[TBL] [Abstract][Full Text] [Related]
11. Stable nanocolloids of poorly soluble drugs with high drug content prepared using the combination of sonication and layer-by-layer technology.
Agarwal A; Lvov Y; Sawant R; Torchilin V
J Control Release; 2008 Jun; 128(3):255-60. PubMed ID: 18479772
[TBL] [Abstract][Full Text] [Related]
12. Design of polyaspartic acid peptide-poly (ethylene glycol)-poly (ε-caprolactone) nanoparticles as a carrier of hydrophobic drugs targeting cancer metastasized to bone.
Liu J; Zeng Y; Shi S; Xu L; Zhang H; Pathak JL; Pan Y
Int J Nanomedicine; 2017; 12():3561-3575. PubMed ID: 28507436
[TBL] [Abstract][Full Text] [Related]
13. Comparison of nanogel drug carriers and their formulations with nucleoside 5'-triphosphates.
Vinogradov SV; Kohli E; Zeman AD
Pharm Res; 2006 May; 23(5):920-30. PubMed ID: 16715382
[TBL] [Abstract][Full Text] [Related]
14. Utilization of green formulation technique and efficacy estimation on cell line studies for dual anticancer drug therapy with niosomes.
Khan DH; Bashir S; Correia A; Khan MI; Figueiredo P; Santos HA; Peltonen L
Int J Pharm; 2019 Dec; 572():118764. PubMed ID: 31628977
[TBL] [Abstract][Full Text] [Related]
15. Formulation and in vitro evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric mixed micelles for glioblastoma multiforme.
Saxena V; Hussain MD
Colloids Surf B Biointerfaces; 2013 Dec; 112():350-5. PubMed ID: 24012704
[TBL] [Abstract][Full Text] [Related]
16. Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo.
Gou M; Men K; Shi H; Xiang M; Zhang J; Song J; Long J; Wan Y; Luo F; Zhao X; Qian Z
Nanoscale; 2011 Apr; 3(4):1558-67. PubMed ID: 21283869
[TBL] [Abstract][Full Text] [Related]
17. A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells.
Shuhendler AJ; Cheung RY; Manias J; Connor A; Rauth AM; Wu XY
Breast Cancer Res Treat; 2010 Jan; 119(2):255-69. PubMed ID: 19221875
[TBL] [Abstract][Full Text] [Related]
18. Surfactant-polymer nanoparticles: a novel platform for sustained and enhanced cellular delivery of water-soluble molecules.
Chavanpatil MD; Khdair A; Panyam J
Pharm Res; 2007 Apr; 24(4):803-10. PubMed ID: 17318416
[TBL] [Abstract][Full Text] [Related]
19. Dual targeting of heat shock proteins 90 and 70 promotes cell death and enhances the anticancer effect of chemotherapeutic agents in bladder cancer.
Ma L; Sato F; Sato R; Matsubara T; Hirai K; Yamasaki M; Shin T; Shimada T; Nomura T; Mori K; Sumino Y; Mimata H
Oncol Rep; 2014 Jun; 31(6):2482-92. PubMed ID: 24718854
[TBL] [Abstract][Full Text] [Related]
20. Delivery of HSP90 Inhibitor Using Water Soluble Polymeric Conjugates with High Drug Payload.
Suárez Del Pino JA; Kolhatkar R
Pharm Res; 2017 Dec; 34(12):2735-2748. PubMed ID: 28913790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]